$CRBP 4 SEC Filings

Filed On	Filing
15 Sep 2026	Form 4: Ben Yong, Director Sold 2,000 shares ($15.7K)
17 Aug 2026	Form 4: Nicacio Leonardo Viana, Chief Medical Officer Received 58,333 shares as a grant or award · Granted 191,676 Stock options (right to buy)
12 Aug 2026	Form 4: Saxena Nishant C, Chief Business Officer Bought 2,600 shares ($25K)
10 Aug 2026	Form 4: Cohen Yuval, Director Sold 17,000 shares ($171K)
10 Aug 2026	Form 4: Moran Sean F., Chief Financial Officer Sold 12,000 shares ($121K)
11 Jun 2026	Form 4: Kung Winston, Director Sold 2,026 shares ($16K)
11 Jun 2026	Form 4: Altmeyer Anne, Director Sold 2,412 shares ($19.1K)
11 Jun 2026	Form 4: Jenkins John Kenneth, Director Sold 4,800 shares ($38K)
03 Jun 2026	Form 4: Saxena Nishant C, Chief Business Officer Bought 4,500 shares ($33K) · Bought 9,000 shares ($68.2K)
22 May 2026	Form 4: Saxena Nishant C, Chief Business Officer Received 58,300 shares as a grant or award · Granted 192,300 Stock options (right to buy)
21 May 2026	Form 4: Kung Winston, Director Received 3,800 shares as a grant or award · Granted 12,300 Stock options (right to buy)
21 May 2026	Form 4: Jacques Rachelle Suzanne, Director Received 3,800 shares as a grant or award · Granted 12,300 Stock options (right to buy)
21 May 2026	Form 4: Jenkins John Kenneth, Director Received 3,800 shares as a grant or award · Granted 12,300 Stock options (right to buy)
21 May 2026	Form 4: Altmeyer Anne, Director Received 3,800 shares as a grant or award · Granted 12,300 Stock options (right to buy)
21 May 2026	Form 4: Ben Yong, Director Received 3,800 shares as a grant or award · Granted 12,300 Stock options (right to buy)
21 May 2026	Form 4: Pfeiffenberger Brent, Director Received 7,500 shares as a grant or award · Granted 24,700 Stock options (right to buy)
04 Mar 2026	Form 4: Smethurst Dominic, Chief Medical Officer Sold 6,097 shares ($50.6K)
18 Feb 2026	Form 4: Hodgson Ian, Chief Operating Officer Sold 847 shares ($6.25K)
18 Feb 2026	Form 4: Moran Sean F., Chief Financial Officer Sold 4,701 shares ($36.6K)
18 Feb 2026	Form 4: Cohen Yuval, Director Sold 13,871 shares ($108K)

Comments